About

Provided by Dechert LLP

Dechert represents buyers, sellers and advisers in sophisticated, complex mergers and acquisitions around the globe. Our deal portfolio includes public and private, negotiated and hostile and multi-million and multi-billion dollar transactions across scores of industries, including financial services, life sciences, healthcare, technology, industrial, consumer, retail, agribusiness, food and beverage, and travel and hospitality.

The M&A practice represents leading private equity firms, public and private companies, global investment advisers and major investment banks. Our imperatives are to structure financeable deals, carry out speed-to-market execution and protect clients’ interests in every transaction phase.

We plan, negotiate and execute the full range of public and private transactions:

  • Acquisitions
  • Divestitures/auctions
  • Joint ventures and collaborations
  • Leveraged buyouts/management buyouts
  • Tender and exchange offers
  • Cross-border transactions
  • Going private-transactions
  • Strategic alliances
  • Proxy contests
  • Special committee assignments
  • Distressed mergers and acquisitions (e.g., bankruptcy)


Chambers Review

Provided by Chambers
Corporate/M&A: Mid-Market - UK
3
Band 3
What the team is known for

Dechert is regularly engaged on domestic and international deals, including matters in emerging markets. It has notable sector strengths in financial services, life sciences and TMT. The team is a mix of both UK and US-qualified lawyers offering a full service to a range of corporates and financial institutions. The corporate offering is bolstered by ancillary expertise in investment funds and financial services regulation.

Notable practitioners

Christopher Field is the co-head of the corporate and private equity group.

Work Highlights

Provided by Dechert LLP
  • Dechert advised Cerus Endovascular on its sale to Stryker Corporation by way of an English scheme of arrangement.

Strengths

Provided by Chambers